Betta Pharmaceuticals Co.,Ltd
- Country
- Ownership
- -
- Established
- 2003-01-07
- Employees
- 1.8K
- Market Cap
- -
- Website
- www.bettapharma.com
- Introduction
Established in 2003, the company is a high-tech pharmaceutical enterprise founded by a team of high-level talents returning from overseas, integrating R&D, production and marketing with independent intellectual property research and development as the core. On November 7, 2016, Betta Pharmaceuticals was listed on the Shenzhen Stock Exchange. The company is a national high-tech enterprise founded by Dr. Overseas Returning, with research and development of innovative drugs with independent intellectual property as the core, integrating R&D, production and marketing. The company's main products Kaimena, Bemena, Beantin, SEMENA, and Vomena are chemical pharmaceuticals. Corporate honors: Chairman Ding Lieming won the title of “Outstanding Person in the Overseas Chinese Community”; Gao Yaqin, the company's senior QC commissioner, won the National May 1st Labor Medal; Chairman Ding Lieming won the Zhejiang Science and Technology Significant Contribution Award; Beida Pharmaceutical won the first “Four Strong Provinces” leading enterprise in Zhejiang; Dr. Ding Lieming won the first “Global Zhejiang Gold Award”, etc.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
16
Drug Approvals
Oryzaol、Vitamin Bland Vitamin B6 Tablet
- Product Name
- 谷维素双维B片
- Approval Number
- 国药准字H33022115
- Approval Date
- Sep 3, 2024
Befotertinib Mesylate Capsules
- Product Name
- 赛美纳
- Approval Number
- 国药准字H20230012
- Approval Date
- Sep 28, 2023
Befotertinib Mesylate Capsules
- Product Name
- 赛美纳
- Approval Number
- 国药准字H20230011
- Approval Date
- Sep 28, 2023
- Prev
- 1
- 2
- Next